Harmony Biosciences
HRMY
HRMY
275 hedge funds and large institutions have $1.62B invested in Harmony Biosciences in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 125 increasing their positions, 68 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
+8
Holders Change %
+3%
% of All Funds
3.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
125
Reduced
68
Closed
30
Calls
$10.5M
Puts
$2.26M
Net Calls
+$8.27M
Net Calls Change
+$4.89M
Top Buyers
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$19.4M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$16.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
| 4 |
Goldman Sachs
New York
|
+$11.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.3M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$28.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.7M |
| 3 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
-$15M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$9.19M |
